Clinical Trials Directory

Trials / Completed

CompletedNCT00710411

Inflammatory Response After Muscle and Skeleton Trauma

Inflammatory Response in Polytraumatized Patients

Status
Completed
Phase
Study type
Observational
Enrollment
48 (actual)
Sponsor
University of Ulm · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the inflammatory response after multiple trauma in humans.

Detailed description

Polytraumatized patients are via a systemic inflammatory response syndrome at high risk for an uneventful outcome in the posttraumatic phase. One of the main functions of the inflammatory response is the recognition and elimination of damaged tissues and microorganisms. In polytraumatized patients, a huge amount of damaged cells occurs which has to be eliminated by programmed cell death (apoptosis)without damaging surrounding tissues. It remains unclear whether, when and how an interplay of complement system, NF-kB, danger and pattern recognition receptors, apoptosis, mesenchymal stem cells and their regulation may be beneficial and harmful. Differing activation of the complement system, pro-inflammatory biomarkers and predisposing polymorphisms of response and receptor genes are expected to lead to varying outcome. Therefore, this prospective observational study will enroll n=60 polytraumatized patients with an ISS\>18 to monitor longitudinally their inflammatory response after trauma and to find out whether there is a discriminating pattern of the cross talk between complement system, biomarkers and apoptosis in patients with beneficial or harmful outcome.

Conditions

Timeline

Start date
2009-04-01
Primary completion
2015-10-01
Completion
2015-12-01
First posted
2008-07-04
Last updated
2015-12-17

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00710411. Inclusion in this directory is not an endorsement.